Publications
A select list of published articles on pancreatic cancer that our team and collaborators have worked on.
- S. Banks, W. Hong, K. Degeling, J. Shapiro, B. Thomson, H. S. Ko, S. Ananda, A. Jalali, Y. H. To, B. Loveday, S.-A. McLachlan, B. Knowles, A. Fox, M. Michael, R. Wong, M. Burge, K. Clarke, S. Pattison, M. Nikfarjam, R. Zielinski, F. Day, C. E. Chee, A. Nagrial, M. IJzerman, P. Gibbs & B. Lee. Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer - an international, multicentre, real-world analysis. ESMO Real World Data and Digital Oncology, Volume 3, 2024, 100022, ISSN 2949-8201. Doi.org/10.1016/j.esmorw.2023.100022
- Mendis S, Lipton L, To YH, Ananda S, Michael M, McLachlan S-A, Thomson B, Loveday B, Knowles B, Fox A, Nikfarjam M, Usatoff V, Shapiro J, Clarke K, Pattison S, Chee CE, Zielinski R, Wong R, Gibbs P and Lee B. Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data. British Journal of Cancer 130, 1477–1484 (2024). Doi.org/10.1038/s41416-024-02619-5
- Williams C, Chong G, Tacey M, Barnett F, Mooi J, Jalali A, Hodgson R, Yong T, Lee B. Addressing disparities in health outcomes for patients with advanced pancreatic cancer and limited English proficiency. Asia Pac J Clin Oncol. 2024 Aug;20(4):531-536. Doi: 10.1111/ajco.14076 . Epub 2024 May 30. PMID: 38813793.
- Lee B, Gately L, Lok SW, Tran B, Lee M, Wong R, Markman B, Dunn K, Wong V, Loft M, Jalili A, Anton A, To R, Andrews M, Gibbs P. Leveraging comprehensive cancer registry data to enable a broad range of research, audit and patient support activities. Cancers 2022, 26 Aug. 14,4131. Doi:10.3390/cancer14174131
- Santucci J, Tacey M, Thomson B, Michael M, Wong R, Shapiro J, Jennens R, Clarke K, Pattison S, Burge M, Zielinski R, Nikfarjam M, Ananda S, Lipton L, Gibbs P, Lee B. Impact of first-line FOLFIRIINOX versus Gemcitabine/ Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international muticentre PURPLE pancreatic cancer registry. European Journal Cancer (EJC) 2022, Aug 2022; 174:102-112. Doi:10.1016/j.ejca.2022.06.042
- Walpole I, Lee B, Shapiro J, Thomson B, Lipton L, Ananda S, Usatoff V, Mclachlan SA, Knowles B, Wong R, Fox A, Cooray P, Burge M, Clarke K, Pattison S, Nikfarjam M, Tebbutt N, Harris M, Nagrial A, Zielinski R, Chee CE, Gibbs P. Uses and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population. July 2022 Asia Pacific J Clin Oncol DOI 10.11111/apjco.13807
- Grogan A, Loveday B, Michael M, Wong HL, Gibbs P, Thomson B, Lee B, Ko HS. Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal adenocarcinoma. ANZ Journal of Surgery. April 2022. Doi:10.1111/ans.17787
- To YH, Shapiro J, Wong R, Thomson B, Nagrial A, Mendis S, Gibbs P, Shapiro J, Lee B. Treatment and outcomes of unresectable and metastatic pancreatic cancer treated in public and private Australian hospitals. Oct 2021. Asia Pacific J Clin Oncol DOI:10.1111/AJCO13721
- Ali A, Wang M, von Scheidt B, Dominguez PM, Harrison AJ, Tantalo D, Kang J, Oliver AJ, Chan JD, Lee B, Johnston R, Darcy PK, Kershaw M, Slaney C. A histone deacetylase inhibitor, panobinostat, enhances chimeric receptor antigen T cell anti-tumor effect against pancreatic cancer. Clinical Cancer Research CCR Aug 2021. DOI: 10.1158/1078-0432.CCR-21-1141 (IF 12.5)
- Low R, Lim W, Nguyen P, Lee B, Christie B, Burgess A, Gibbs P, Grimmond S, Hollande F, Putoczki T. Pancreatic ductal adenocarcinoma organoids: an opportunity to identify new treatments. Cancers 2021, 13, 4979. doi.org/10.3390/cancers13194979
Awards
The following awards recognise the achievement of our PURPLE Translational Platform projects and our researchers at recent national and international scientific symposiums.
- Premier’s Awards for Health and Medical Research (2021 Finalist)
- American Roentgen Ray Society (ARRS) April 2021 (Merit Award)
- Grogan A, Banks S… Lee B & Ko H. Comparison of pre-operative subspecialist CT versus post-operative histopathological staging of pancreatic ductal adenocarcinoma.
- Clinical Oncology Society of Australia (COSA) Annual Scientific Symposium, Nov 2020 (Best Translational Research Award)
- Banks S, Grogan A, …Ko H, & Lee B. Developing a predictive model utilising real-world pancreatic cancer data and CT-based radiomics for implementation into clinical practice.